Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia.
about
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Systematic review and meta-ana ...... for chronic myeloid leukemia.
@en
type
label
Systematic review and meta-ana ...... for chronic myeloid leukemia.
@en
prefLabel
Systematic review and meta-ana ...... for chronic myeloid leukemia.
@en
P2093
P2860
P1476
Systematic review and meta-ana ...... for chronic myeloid leukemia.
@en
P2093
Joerg Hasford
Michael Deininger
Rüdiger Hehlmann
Verena S Hoffmann
P2860
P2888
P304
P356
10.1007/S00432-017-2385-7
P577
2017-03-08T00:00:00Z